Hollings Home  
 
Charles L Bennett, MD, PhD
Professor of Clinical Pharmacy & Outcome Sciences
College of Pharmacy
USC

Email: bennettc@sccp.sc.edu
 
       Print This Page
       
 
 


 

Charles L Bennett, MD, PhD

Return to Search Page  

Research Interest:

My research interests include the identification and dissemination of information on adverse drug reactions; costs and quality of cancer care; health policy and minority issues for cancer patients; low literacy; and cancer prevention, screening, detection, and treatment. I am the principal investigator for the independent pharmaceutical safety program, the Research on Adverse Drug Events and Reports (RADAR) project, a National Institute of Health funded program that evaluates the safety of pharmaceuticals and medical devices with annual sales of $1 billion or greater. In the past decade, RADAR has identified 38 potentially fatal and previously unrecognized adverse drug reactions. The result has been improved safety information on product labels and savings of thousands of lives. All of the identified drugs or devices continue to have robust sales, but at the same time, their safety profiles have been improved.

Honors:
Endowed Chair in Medication Safety and Efficacy, SmartState Center of Economic Excellence

Selected Publications:

1.Bennett CL, Hermanson T. Is Intravenous Iron Supplementation Safe to Administer to Patients on Hemodialysis with Active Infection-What Do We Know, and What More Do We Need to Know? Clin J Am Soc Nephrol. .10(10):1714-5, 2015. PMID: 26416944 PMCID: PMC4594072
View in: PubMed

2.Hermanson TT, Hrushesky WJ, Knopf KB, Bennett CL. Adding Bevacizumab to the Treatment of Patients With Non-Small-Cell Lung Cancer: Caveat Emptor. J Oncol Pract. .11(5):363-4, 2015. PMID: 26243648
View in: PubMed

3.Prasad S, Hermanson T, Bennett CL, Sartor AO. Editorial Comment. Urology. .86(1):78, 2015. PMID: 26142588
View in: PubMed

4.Isonishi A, Bennett CL, Plaimauer B, Scheiflinger F, Matsumoto M, Fujimura Y. Poor responder to plasma exchange therapy in acquired thrombotic thrombocytopenic purpura is associated with ADAMTS13 inhibitor boosting: visualization of an ADAMTS13 inhibitor complex and its proteolytic clearance from plasma. Transfusion. .55(10):2321-30, 2015. PMID: 26058519
View in: PubMed

5.Mahal BA, Chen MH, Bennett CL, Kattan MW, Sartor O, Stein K, D'Amico AV, Nguyen PL. High PSA anxiety and low health literacy skills: drivers of early use of salvage ADT among men with biochemically recurrent prostate cancer after radiotherapy? Ann Oncol. .26(7):1390-5, 2015. PMID: 25926039 PMCID: PMC4478973
View in: PubMed

6.Prasad SM, Sartor AO, Bennett CL. Population-Based Assessment of Determining Treatments for Prostate Cancer. JAMA Oncol. .1(1):67-8, 2015. PMID: 26182306
View in: PubMed

7.Bennett CL, Chen B, Hermanson T, Georgantopoulos P, Sartor OA. Japanese regulatory authority's perspective on biosimilars - authors' reply. Lancet Oncol. .16(3):e102, 2015. PMID: 25752553
View in: PubMed

8.Davis TC, Arnold CL, Bennett CL, Wolf MS, Liu D, Rademaker A. Sustaining mammography screening among the medically underserved: a follow-up evaluation. J Womens Health (Larchmt). .24(4):291-8, 2015. PMID: 25692910 PMCID: PMC4394885
View in: PubMed

9.Yada N, Fujioka M, Bennett CL, Inoki K, Miki T, Watanabe A, Yoshida T, Hayakawa M, Matsumoto M, Fujimura Y. STEC:O111-HUS complicated by acute encephalopathy in a young girl was successfully treated with a set of hemodiafiltration, steroid pulse, and soluble thrombomodulin under plasma exchange. Clin Case Rep. .3(4):208-12, 2015. PMID: 25914810 PMCID: PMC4405303
View in: PubMed

10.Hermanson T, Sartor O, Ablin R, Bennett CL. Editorial comment. Urology. .85(2):413, 2015. PMID: 25623704
View in: PubMed

11.Sartor O, Pal SK, Hermanson T, Bennett CL. Geography: an increasingly important variable in prostate cancer clinical trials. BJU Int. .115(1):2-3, 2015. PMID: 25510569
View in: PubMed

12.Lu ZK, Yuan J, Li M, Sutton SS, Rao GA, Jacob S, Bennett CL. Cardiac risks associated with antibiotics: azithromycin and levofloxacin. Expert Opin Drug Saf. .14(2):295-303, 2014. PMID: 25494485 PMCID: PMC4404501
View in: PubMed

13.Bennett CL, Chen B, Hermanson T, Wyatt MD, Schulz RM, Georgantopoulos P, Kessler S, Raisch DW, Qureshi ZP, Lu ZK, Love BL, Noxon V, Bobolts L, Armitage M, Bian J, Ray P, Ablin RJ, Hrushesky WJ, Macdougall IC, Sartor O, Armitage JO. Regulatory and clinical considerations for biosimilar oncology drugs. Lancet Oncol. .15(13):e594-605, 2014. PMID: 25456378 PMCID: PMC4404762
View in: PubMed

14.Hermanson T, Sartor O, Ablin RJ, Bennett CL. Editorial comment. Urology. .84(5):1072, 2014. PMID: 25443906
View in: PubMed

15.Sartor O, Bennett CL. Editorial comment. Urology. .85(1):153-4, 2014. PMID: 25530377
View in: PubMed

16.Hermanson T, Norris LB, Bian J, Sartor O, Bennett CL. Toxicity and costs of toxicity associated with new cancer drugs: international implications. J Clin Oncol. .32(32):3591-2, 2014. PMID: 25267755
View in: PubMed

17.Systemic therapy in men with metastatic castration-resistant prostate cancer:American Society of Clinical Oncology and Cancer Care Ontario clinical practice guideline. J Clin Oncol. .32(30):3436-48, 2014. PMID: 25199761
View in: PubMed

18.Bennett CL, Newsome SD, Sartor O, Carson KR. Reply to magnetic resonance imaging-based diagnosis of progressive multifocal leukoencephalopathy in a patient with non-Hodgkin lymphoma after therapy with cyclophosphamide, doxorubicin, vincristine, prednisone, and rituximab. Cancer. .120(24):4006-7, 2014. PMID: 25123754 PMCID: PMC4440419
View in: PubMed

19.Bennett CL, Bian J. Erythropoiesis-stimulating agents and quality of life: personal journeys of a cancer survivor, oncologist, and two cancer health services researchers. Br J Cancer. .111(3):421-3, 2014. PMID: 25072302 PMCID: PMC4119972
View in: PubMed

20.Bennett CL, Jacob S, Hymes J, Usvyat LA, Maddux FW. Anaphylaxis and hypotension after administration of peginesatide. N Engl J Med. .370(21):2055-6, 2014. PMID: 24849101 PMCID: PMC4200528
View in: PubMed

21.Kumthekar P, Stell BV, Jacobs DI, Helenowski IB, Rademaker AW, Grimm SA, Bennett CL, Raizer JJ. Financial burden experienced by patients undergoing treatment for malignant gliomas. Neurooncol Pract. .1(2):71-76, 2014. PMID: 26034619 PMCID: PMC4371162
View in: PubMed

22.Carson KR, Newsome SD, Kim EJ, Wagner-Johnston ND, von Geldern G, Moskowitz CH, Moskowitz AJ, Rook AH, Jalan P, Loren AW, Landsburg D, Coyne T, Tsai D, Raisch DW, Norris LB, Bookstaver PB, Sartor O, Bennett CL. Progressive multifocal leukoencephalopathy associated with brentuximab vedotin therapy: a report of 5 cases from the Southern Network on Adverse Reactions (SONAR) project. Cancer. .120(16):2464-71, 2014. PMID: 24771533 PMCID: PMC4460831
View in: PubMed

23.Prasad SM, Sartor O, Bennett CL. Editorial comment. Urology. .83(4):786-7, 2014. PMID: 24680449
View in: PubMed

24.Rao GA, Mann JR, Shoaibi A, Bennett CL, Nahhas G, Sutton SS, Jacob S, Strayer SM. Azithromycin and levofloxacin use and increased risk of cardiac arrhythmia and death. Ann Fam Med. .12(2):121-7, 2014. PMID: 24615307 PMCID: PMC3948758
View in: PubMed

25.Maxwell WD, Jacob M, Spiryda LB, Bennett CL. Selection of contraceptive therapy for patients with thrombophilia: a review of the evidence. J Womens Health (Larchmt). .23(4):318-26, 2014. PMID: 24552487
View in: PubMed

26.Prasad SM, Sartor O, Bennett CL. Reply to W. Read. J Clin Oncol. .32(6):604-5, 2014. PMID: 24395847
View in: PubMed

27.Davis TC, Rademaker A, Bennett CL, Wolf MS, Carias E, Reynolds C, Liu D, Arnold CL. Improving mammography screening among the medically underserved. J Gen Intern Med. .29(4):628-35, 2013. PMID: 24366401 PMCID: PMC3965756
View in: PubMed

28.Hamed S, Bennett CL, Demiot C, Ullmann Y, Teot L, Desmoulière A. Erythropoietin, a novel repurposed drug: an innovative treatment for wound healing in patients with diabetes mellitus. Wound Repair Regen. .22(1):23-33, 2013. PMID: 24471742
View in: PubMed

29.Prasad SM, Sartor AO, Bennett CL. Editorial comment. Urology. .83(1):152-3; discussion 153, 2013. PMID: 24238571
View in: PubMed

30.Davis TC, Arnold CL, Bennett CL, Wolf MS, Reynolds C, Liu D, Rademaker A. Strategies to improve repeat fecal occult blood testing cancer screening. Cancer Epidemiol Biomarkers Prev. .23(1):134-43, 2013. PMID: 24192009 PMCID: PMC3894742
View in: PubMed

31.Magwood JS, Lebby A, Chen B, Kessler S, Norris L, Bennett CL. Emerging drugs for treatment of anemia of chronic kidney disease. Expert Opin Emerg Drugs. .18(4):421-9, 2013. PMID: 24033253
View in: PubMed

32.Kessler SJ, Bennett CL. Forewarned is forearmed: erythropoietin use in CKD patients with cancer. J Nephrol. .26(5):805-6, 2013. PMID: 24052466
View in: PubMed

33.Rao GA, Mann JR, Shoaibi A, Pai SG, Bottai M, Sutton SS, Haddock KS, Bennett CL, Hebert JR. Angiotensin receptor blockers: are they related to lung cancer? J Hypertens. .31(8):1669-75, 2013. PMID: 23822929 PMCID: PMC3879726
View in: PubMed

34.Prasad SM, Bennett CL. Finishing the picture: problems with public reporting of clinical trials. J Clin Oncol. .31(24):2981-2, 2013. PMID: 23878296
View in: PubMed

35.Strassels SA, Dickson M, Norris LB, Bennett CL. Primary prophylaxis with hematopoietic colony stimulating factor: insights from a Canadian cost-effectiveness analysis. J Natl Cancer Inst. .105(15):1072-3, 2013. PMID: 23873406 PMCID: PMC3735465
View in: PubMed

36.Djulbegovic B, Norris LB, Bennett CL. Colony-stimulating factors for febrile neutropenia. N Engl J Med. .369(3):286, 2013. PMID: 23863062
View in: PubMed

37.Crawford ED, Bennett CL, Andriole GL, Garnick MB, Petrylak DP. The utility of prostate-specific antigen in the management of advanced prostate cancer. BJU Int. .112(5):548-60, 2013. PMID: 23826876
View in: PubMed

38.Prasad SM, Bennett CL. Editorial comment. Urology. .82(1):66, 2013. PMID: 23706256
View in: PubMed

39.Rao GA, Mann JR, Bottai M, Uemura H, Burch JB, Bennett CL, Haddock KS, Hébert JR. Angiotensin receptor blockers and risk of prostate cancer among United States veterans. J Clin Pharmacol. .53(7):773-8, 2013. PMID: 23686462 PMCID: PMC3768141
View in: PubMed

40.Li YJ, Xirasagar S, Pumkam C, Krishnaswamy M, Bennett CL. Vision insurance, eye care visits, and vision impairment among working-age adults in the United States. JAMA Ophthalmol. .131(4):499-506, 2013. PMID: 23710504
View in: PubMed

41.Bennett CL, Jacob S, Dunn BL, Georgantopoulos P, Zheng XL, Kwaan HC, McKoy JM, Magwood JS, Qureshi ZP, Bandarenko N, Winters JL, Raife TJ, Carey PM, Sarode R, Kiss JE, Danielson C, Ortel TL, Clark WF, Ablin RJ, Rock G, Matsumoto M, Fujimura Y. Ticlopidine-associated ADAMTS13 activity deficient thrombotic thrombocytopenic purpura in 22 persons in Japan: a report from the Southern Network on Adverse Reactions (SONAR). Br J Haematol. .161(6):896-8, 2013. PMID: 23530950 PMCID: PMC3804577
View in: PubMed

42.Bennett CL, Djulbegovic B, Norris LB, Armitage JO. Colony-stimulating factors for febrile neutropenia during cancer therapy. N Engl J Med. .368(12):1131-9, 2013. PMID: 23514290 PMCID: PMC3947590
View in: PubMed

43.Victorson DE, Brucker PS, Bode RK, Eton DT, Talcott JA, Clark JA, Knight SJ, Litwin MS, Moinpour CM, Reeve BB, Aaronson NK, Bennett CL, Herr HW, McGuire M, Shevrin D, McVary K, Cella D. Ensuring comprehensive assessment of urinary problems in prostate cancer through patient-physician concordance. Urol Oncol. .32(1):26.e25-31, 2013. PMID: 23522840
View in: PubMed

44.Sutton SS, Stacy JJ, Mensch J, Torres-McGehee T, Bennett CL. Tackling community-acquired methicillin-resistant Staphylococcus aureus in collegiate football players following implementation of an anti-MRSA programme. Br J Sports Med. .48(4):284-5, 2013. PMID: 23418268
View in: PubMed

45.Parekh A, Chen MH, Hoffman KE, Choueiri TK, Hu JC, Bennett CL, Kattan MW, Sartor O, Stein K, Graham PL, D'Amico AV, Nguyen PL. Reduced penile size and treatment regret in men with recurrent prostate cancer after surgery, radiotherapy plus androgen deprivation, or radiotherapy alone. Urology. .81(1):130-4, 2013. PMID: 23273077
View in: PubMed

46.Prasad SM, Bennett CL. Editorial comment. Urology. .81(1):154; author reply 154, 2013. PMID: 23273083
View in: PubMed

47.Cunningham JE, Walters CA, Hill EG, Ford ME, Barker-Elamin T, Bennett CL. Mind the gap: racial differences in breast cancer incidence and biologic phenotype, but not stage, among low-income women participating in a government-funded screening program. Breast Cancer Res Treat. .137(2):589-98, 2012. PMID: 23239148 PMCID: PMC3660400
View in: PubMed

48.Maxwell W, Bennett CL. Will newer anticoagulants improve therapy persistence? Arch Intern Med. .172(21):1689-90, 2012. PMID: 23089938
View in: PubMed

49.Kwaan HC, Bennett CL. Adverse effects of drugs on hemostasis and thrombosis. Semin Thromb Hemost. .38(8):755-8, 2012. PMID: 23129499
View in: PubMed

50.Bennett CL, Spiegel DM, Macdougall IC, Norris L, Qureshi ZP, Sartor O, Lai SY, Tallman MS, Raisch DW, Smith SW, Silver S, Murday AS, Armitage JO, Goldsmith D. A review of safety, efficacy, and utilization of erythropoietin, darbepoetin, and peginesatide for patients with cancer or chronic kidney disease: a report from the Southern Network on Adverse Reactions (SONAR). Semin Thromb Hemost. .38(8):783-96, 2012. PMID: 23111861 PMCID: PMC3947540
View in: PubMed

51.Jacob S, Dunn BL, Qureshi ZP, Bandarenko N, Kwaan HC, Pandey DK, McKoy JM, Barnato SE, Winters JL, Cursio JF, Weiss I, Raife TJ, Carey PM, Sarode R, Kiss JE, Danielson C, Ortel TL, Clark WF, Rock G, Matsumoto M, Fujimura Y, Zheng XL, Chen H, Chen F, Armstrong JM, Raisch DW, Bennett CL. Ticlopidine-, clopidogrel-, and prasugrel-associated thrombotic thrombocytopenic purpura: a 20-year review from the Southern Network on Adverse Reactions (SONAR). Semin Thromb Hemost. .38(8):845-53, 2012. PMID: 23111862 PMCID: PMC3804561
View in: PubMed

52.Maxwell WD, Bennett CL. Thromboprophylaxis guidelines in cancer with a primary focus on ambulatory patients receiving chemotherapy: a review from the Southern Network on Adverse Reactions (SONAR). Semin Thromb Hemost. .38(8):759-67, 2012. PMID: 23111863 PMCID: PMC4017864
View in: PubMed

53.Moore TJ, Bennett CL. Underreporting of hemorrhagic and thrombotic complications of pharmaceuticals to the U.S. Food and Drug Administration: empirical findings for warfarin, clopidogrel, ticlopidine, and thalidomide from the Southern Network on Adverse Reactions (SONAR). Semin Thromb Hemost. .38(8):905-7, 2012. PMID: 23086541 PMCID: PMC3947536
View in: PubMed

54.Bian J, Bennett CL, Fisher DA, Ribeiro M, Lipscomb J. Unintended consequences of health information technology: evidence from veterans affairs colorectal cancer oncology watch intervention. J Clin Oncol. .30(32):3947-52, 2012. PMID: 23045582 PMCID: PMC3488268
View in: PubMed

55.Chen B, Restaino J, Norris L, Xirasagar S, Qureshi ZP, McKoy JM, Lopez IS, Trenery A, Murday A, Kahn A, Mattison DR, Ray P, Sartor O, Bennett CL. A tale of two citizens: a State Attorney General and a hematologist facilitate translation of research into US Food and Drug Administration actions--a SONAR report. J Oncol Pract. .8(6):e158-67, 2012. PMID: 23598851 PMCID: PMC3500490
View in: PubMed

56.Kyriacou DN, Dobrez D, Parada JP, Steinberg JM, Kahn A, Bennett CL, Schmitt BP. Cost-effectiveness comparison of response strategies to a large-scale anthrax attack on the chicago metropolitan area: impact of timing and surge capacity. Biosecur Bioterror. .10(3):264-79, 2012. PMID: 22845046 PMCID: PMC3440066
View in: PubMed

57.Prasad SM, Keane T, Bennett CL. Editorial comment. Urology. .80(3):563, 2012. PMID: 22789296
View in: PubMed

58.Bennett CL, Starko KM, Thomsen HS, Cowper S, Sartor O, Macdougall IC, Qureshi ZP, Bookstaver PB, Miller AD, Norris LB, Xirasagar S, Trenery A, Lopez I, Kahn A, Murday A, Luminari S, Cournoyer D, Locatelli F, Ray P, Mattison DR. Linking drugs to obscure illnesses: lessons from pure red cell aplasia, nephrogenic systemic fibrosis, and Reye's syndrome. a report from the Southern Network on Adverse Reactions (SONAR). J Gen Intern Med. .27(12):1697-703, 2012. PMID: 22692632 PMCID: PMC3509314
View in: PubMed

59.Prasad SM, Keane TE, Bennett CL. Editorial comment. Urology. .80(1):168, 2012. PMID: 22608794
View in: PubMed

60.Passman RS, Bennett CL, Purpura JM, Kapur R, Johnson LN, Raisch DW, West DP, Edwards BJ, Belknap SM, Liebling DB, Fisher MJ, Samaras AT, Jones LG, Tulas KM, McKoy JM. Amiodarone-associated optic neuropathy: a critical review. Am J Med. .125(5):447-53, 2012. PMID: 22385784 PMCID: PMC3322295
View in: PubMed

61.Bennett CL. A 56-year-old physician who underwent a PSA test. Arch Intern Med. .172(4):311, 2012. PMID: 22371918
View in: PubMed

62.Bennett CL, Qureshi ZP, Sartor AO, Norris LB, Murday A, Xirasagar S, Thomsen HS. Gadolinium-induced nephrogenic systemic fibrosis: the rise and fall of an iatrogenic disease. Clin Kidney J. .5(1):82-88, 2012. PMID: 22833806 PMCID: PMC3341839
View in: PubMed

63.Qureshi ZP, Norris L, Sartor O, McKoy JM, Armstrong J, Raisch DW, Garg V, Stafkey-Mailey D, Bennett CL. Caveat oncologist: clinical findings and consequences of distributing counterfeit erythropoietin in the United States. J Oncol Pract. .8(2):84-90, 2011. PMID: 23077434 PMCID: PMC3457834
View in: PubMed

64.Nguyen PL, Chen MH, Hoffman KE, Chen RC, Hu JC, Bennett CL, Kattan MW, Sartor O, Stein K, D'Amico AV. Cardiovascular comorbidity and treatment regret in men with recurrent prostate cancer. BJU Int. .110(2):201-5, 2011. PMID: 22085233
View in: PubMed

65.Bennett CL. Pharmacovigilance and PML in the oncology setting. Cleve Clin J Med. .78 Suppl 2:S13-7, 2011. PMID: 22123927
View in: PubMed

66.Qureshi ZP, Sartor O, Xirasagar S, Liu Y, Bennett CL. Pharmaceutical fraud and abuse in the United States, 1996-2010. Arch Intern Med. .171(16):1503-6, 2011. PMID: 21911639
View in: PubMed

67.Felder TM, Lal LS, Bennett CL, Hung F, Franzini L. Cancer patients' use of pharmaceutical patient assistance programs in the outpatient pharmacy at a large tertiary cancer center. Community Oncol. .8(6):279-286, 2011. PMID: 22879815 PMCID: PMC3413301
View in: PubMed

68.Raisch DW, Campbell W, Garg V, Qureshi ZP, Bookstaver PB, Norris LB, Bennett CL. Description of anaphylactic reactions to paclitaxel and docetaxel reported to the FDA, with a focus on the role of premedication. Expert Opin Drug Saf. .10(4):521-8, 2011. PMID: 21595611
View in: PubMed

69.Qureshi ZP, Liu Y, Sartor O, Chu YH, Bennett CL. Enforcement actions involving Medicaid fraud and abuse, 1996-2009. Arch Intern Med. .171(8):785-7, 2011. PMID: 21518950
View in: PubMed

70.Miller AD, Ball AM, Bookstaver PB, Dornblaser EK, Bennett CL. Epileptogenic potential of carbapenem agents: mechanism of action, seizure rates, and clinical considerations. Pharmacotherapy. .31(4):408-23, 2011. PMID: 21449629
View in: PubMed

71.Edwards BJ, Raisch DW, Shankaran V, McKoy JM, Gradishar W, Bunta AD, Samaras AT, Boyle SN, Bennett CL, West DP, Guise TA. Cancer therapy associated bone loss: implications for hip fractures in mid-life women with breast cancer. Clin Cancer Res. .17(3):560-8, 2011. PMID: 21288927 PMCID: PMC3058419
View in: PubMed

72.Mortimer JE, Barsevick AM, Bennett CL, Berger AM, Cleeland C, DeVader SR, Escalante C, Gilreath J, Hurria A, Mendoza TR, Rugo HS. Studying cancer-related fatigue: report of the NCCN scientific research committee. J Natl Compr Canc Netw. .8(12):1331-9, 2010. PMID: 21147900
View in: PubMed

73.Xirasagar S, Bennett CL, Hebert JR. Screening colonoscopy vs flexible sigmoidoscopy. JAMA. .304(18):2016-7; author reply 2017-8, 2010. PMID: 21063009
View in: PubMed

74.Miller AD, Piro CC, Rudisill CN, Bookstaver PB, Bair JD, Bennett CL. Nighttime and weekend medication error rates in an inpatient pediatric population. Ann Pharmacother. .44(11):1739-46, 2010. PMID: 20959503
View in: PubMed

75.Bennett CL, Lai SY, Henke M, Barnato SE, Armitage JO, Sartor O. Association between pharmaceutical support and basic science research on erythropoiesis-stimulating agents. Arch Intern Med. .170(16):1490-8, 2010. PMID: 20837837 PMCID: PMC4138541
View in: PubMed

76.Ablin RJ, Sartor O, Bennett CL. Invited commentary: Prostate cancer: doing less might be more. Comment on "Severity of comorbidity and non-prostate cancer mortality in men with early-stage prostate cancer". Arch Intern Med. .170(15):1397-9, 2010. PMID: 20696969
View in: PubMed

77.Mayhew R, McKoy JM, Ha Luu T, Lopez I, Frick M, Bennett CL. Adverse drug interactions: moving from perception to action. Pharmacoeconomics. .28(1):19-22, 2010. PMID: 20014873
View in: PubMed

78.Richey EA, Lyons EA, Nebeker JR, Shankaran V, McKoy JM, Luu TH, Nonzee N, Trifilio S, Sartor O, Benson AB, Carson KR, Edwards BJ, Gilchrist-Scott D, Kuzel TM, Raisch DW, Tallman MS, West DP, Hirschfeld S, Grillo-Lopez AJ, Bennett CL. Accelerated approval of cancer drugs: improved access to therapeutic breakthroughs or early release of unsafe and ineffective drugs? J Clin Oncol. .27(26):4398-405, 2009. PMID: 19636013 PMCID: PMC2744277
View in: PubMed

79.Simon MA, Dong X, Bennett CL. Partnering to promote equality in cancer care. Soc Work Public Health. .24(4):355-9, 2009. PMID: 19517300
View in: PubMed

80.McKoy JM, Samaras AT, Luu TH, Bennett CL. Upping recruitment in clinical trials: are the costs worth it? Onkologie. .32(7):378-9, 2009. PMID: 19556813
View in: PubMed

81.Dorr DA, Burdon R, West DP, Lagman J, Georgopoulos C, Belknap SM, McKoy JM, Djulbegovic B, Edwards BJ, Weitzman SA, Boyle S, Tallman MS, Talpaz M, Sartor O, Bennett CL. Quality of reporting of serious adverse drug events to an institutional review board: a case study with the novel cancer agent, imatinib mesylate. Clin Cancer Res. .15(11):3850-5, 2009. PMID: 19458059 PMCID: PMC3296235
View in: PubMed

82.McKoy JM, Samaras AT, Bennett CL. Providing cancer care to a graying and diverse cancer population in the 21st century: are we prepared? J Clin Oncol. .27(17):2745-6, 2009. PMID: 19403884
View in: PubMed

83.Simon MA, Dong X, Nonzee N, Bennett CL. Heeding our words: complexities of research among low-literacy populations. J Clin Oncol. .27(12):1938-40, 2009. PMID: 19307497
View in: PubMed

84.Carson KR, Evens AM, Richey EA, Habermann TM, Focosi D, Seymour JF, Laubach J, Bawn SD, Gordon LI, Winter JN, Furman RR, Vose JM, Zelenetz AD, Mamtani R, Raisch DW, Dorshimer GW, Rosen ST, Muro K, Gottardi-Littell NR, Talley RL, Sartor O, Green D, Major EO, Bennett CL. Progressive multifocal leukoencephalopathy after rituximab therapy in HIV-negative patients: a report of 57 cases from the Research on Adverse Drug Events and Reports project. Blood. .113(20):4834-40, 2009. PMID: 19264918 PMCID: PMC2686134
View in: PubMed

85.Carson KR, Bennett CL. Rituximab and progressive multi-focal leukoencephalopathy: the jury is deliberating. Leuk Lymphoma. .50(3):323-4, 2009. PMID: 19347724
View in: PubMed

86.Wideroff L, Phillips KA, Randhawa G, Ambs A, Armstrong K, Bennett CL, Brown ML, Donaldson MS, Follen M, Goldie SJ, Hiatt RA, Khoury MJ, Lewis G, McLeod HL, Piper M, Powell I, Schrag D, Schulman KA, Scott J. A health services research agenda for cellular, molecular and genomic technologies in cancer care. Public Health Genomics. .12(4):233-44, 2009. PMID: 19367091 PMCID: PMC2844634
View in: PubMed

87.Pickard AS, Lin HW, Knight SJ, Knight SL, Sharifi R, Wu Z, Hung SY, Witt WP, Chang CH, Bennett CL. Proxy assessment of health-related quality of life in african american and white respondents with prostate cancer: perspective matters. Med Care. .47(2):176-83, 2009. PMID: 19169118 PMCID: PMC3215256
View in: PubMed

88.Zakarija A, Kwaan HC, Moake JL, Bandarenko N, Pandey DK, McKoy JM, Yarnold PR, Raisch DW, Winters JL, Raife TJ, Cursio JF, Luu TH, Richey EA, Fisher MJ, Ortel TL, Tallman MS, Zheng XL, Matsumoto M, Fujimura Y, Bennett CL. Ticlopidine- and clopidogrel-associated thrombotic thrombocytopenic purpura (TTP): review of clinical, laboratory, epidemiological, and pharmacovigilance findings (1989-2008). Kidney Int Suppl. .(112):S20-4, 2009. PMID: 19180126 PMCID: PMC3500614
View in: PubMed

89.McKoy JM, Bolden CR, Samaras A, Raisch DW, Chandler K, Bennett CL. Sildenafil- and tadalafil-associated optic neuropathy: implications for men after prostate cancer treatment. Community Oncol. .6(2):78-80, 2009. PMID: 20046540 PMCID: PMC2800378
View in: PubMed

90.Bilimoria KY, Bentrem DJ, Wayne JD, Ko CY, Bennett CL, Talamonti MS. Small bowel cancer in the United States: changes in epidemiology, treatment, and survival over the last 20 years. Ann Surg. .249(1):63-71, 2009. PMID: 19106677
View in: PubMed

91.McKoy JM, Bennett CL, Scheetz MH, Differding V, Chandler KL, Scarsi KK, Yarnold PR, Sutton S, Palella F, Johnson S, Obadina E, Raisch DW, Parada JP. Hepatotoxicity associated with long- versus short-course HIV-prophylactic nevirapine use: a systematic review and meta-analysis from the Research on Adverse Drug events And Reports (RADAR) project. Drug Saf. .32(2):147-58, 2009. PMID: 19236121 PMCID: PMC2768573
View in: PubMed

92.Bennett CL, Becker PS, Kraut EH, Samaras AT, West DP. Intersecting guidelines: administering erythropoiesis-stimulating agents to chronic kidney disease patients with cancer. Semin Dial. .22(1):1-4, 2008. PMID: 19175532 PMCID: PMC3296236
View in: PubMed

93.Edwards BJ, Gounder M, McKoy JM, Boyd I, Farrugia M, Migliorati C, Marx R, Ruggiero S, Dimopoulos M, Raisch DW, Singhal S, Carson K, Obadina E, Trifilio S, West D, Mehta J, Bennett CL. Pharmacovigilance and reporting oversight in US FDA fast-track process: bisphosphonates and osteonecrosis of the jaw. Lancet Oncol. .9(12):1166-72, 2008. PMID: 19038763
View in: PubMed

94.Nonzee NJ, Dandade NA, Patel U, Markossian T, Agulnik M, Argiris A, Patel JD, Kern RC, Munshi HG, Calhoun EA, Bennett CL. Evaluating the supportive care costs of severe radiochemotherapy-induced mucositis and pharyngitis : results from a Northwestern University Costs of Cancer Program pilot study with head and neck and nonsmall cell lung cancer patients who received care at a county hospital, a Veterans Administration hospital, or a comprehensive cancer care center. Cancer. .113(6):1446-52, 2008. PMID: 18683883
View in: PubMed

95.Wagman LD, Baird MF, Bennett CL, Bockenstedt PL, Cataland SR, Fanikos J, Fogarty PF, Goldhaber SZ, Grover TS, Haire W, Hassoun H, Hutchinson S, Jahanzeb M, Lee J, Linenberger ML, Millenson MM, Ortel TL, Salem R, Smith JL, Streiff MB, Vedantham S. Venous thromboembolic disease. NCCN. Clinical practice guidelines in oncology. J Natl Compr Canc Netw. .6(8):716-53, 2008. PMID: 18926086
View in: PubMed

96.Rodgers GM, Becker PS, Bennett CL, Cella D, Chanan-Khan A, Chesney C, Cleeland C, Coccia PF, Djulbegovic B, Garst JL, Gilreath JA, Kraut EH, Lin WC, Matulonis U, Millenson M, Reinke D, Rosenthal J, Sabbatini P, Schwartz RN, Stein RS, Vij R. Cancer- and chemotherapy-induced anemia. J Natl Compr Canc Netw. .6(6):536-64, 2008. PMID: 18597709
View in: PubMed

97.McKoy JM, Stonecash RE, Cournoyer D, Rossert J, Nissenson AR, Raisch DW, Casadevall N, Bennett CL. Epoetin-associated pure red cell aplasia: past, present, and future considerations. Transfusion. .48(8):1754-62, 2008. PMID: 18482185 PMCID: PMC2730535
View in: PubMed

98.Bennett CL, Silver SM, Djulbegovic B, Samaras AT, Blau CA, Gleason KJ, Barnato SE, Elverman KM, Courtney DM, McKoy JM, Edwards BJ, Tigue CC, Raisch DW, Yarnold PR, Dorr DA, Kuzel TM, Tallman MS, Trifilio SM, West DP, Lai SY, Henke M. Venous thromboembolism and mortality associated with recombinant erythropoietin and darbepoetin administration for the treatment of cancer-associated anemia. JAMA. .299(8):914-24, 2008. PMID: 18314434
View in: PubMed

99.McKoy JM, Tigue CC, Bennett CL. Does reimbursement affect physicians' decision making? Examples from the use of recombinant erythropoietin. Cancer Treat Res. .140:235-51, 2008. PMID: 18283779
View in: PubMed

100.McKoy JM, Laumann A, Samaras A, Lacouture M, West D, Raisch D, Obadina E, Fajolu O, Reilly L, Bennett CL. Gadolinium-associated nephrogenic systemic fibrosis. Community Oncol. .5(6):325-326, 2008. PMID: 19920874 PMCID: PMC2777717
View in: PubMed

101.Shankaran V, McKoy JM, Dandade N, Nonzee N, Tigue CA, Bennett CL, Denberg TD. Costs and cost-effectiveness of a low-intensity patient-directed intervention to promote colorectal cancer screening. J Clin Oncol. .25(33):5248-53, 2007. PMID: 18024871
View in: PubMed

102.Rizzo JD, Somerfield MR, Hagerty KL, Seidenfeld J, Bohlius J, Bennett CL, Cella DF, Djulbegovic B, Goode MJ, Jakubowski AA, Rarick MU, Regan DH, Lichtin AE. Use of epoetin and darbepoetin in patients with cancer: 2007 American Society of Hematology/American Society of Clinical Oncology clinical practice guideline update. Blood. .111(1):25-41, 2007. PMID: 17954703
View in: PubMed

103.Bennett CL, Kim B, Zakarija A, Bandarenko N, Pandey DK, Buffie CG, McKoy JM, Tevar AD, Cursio JF, Yarnold PR, Kwaan HC, De Masi D, Sarode R, Raife TJ, Kiss JE, Raisch DW, Davidson C, Sadler JE, Ortel TL, Zheng XL, Kato S, Matsumoto M, Uemura M, Fujimura Y. Two mechanistic pathways for thienopyridine-associated thrombotic thrombocytopenic purpura: a report from the SERF-TTP Research Group and the RADAR Project. J Am Coll Cardiol. .50(12):1138-43, 2007. PMID: 17868804 PMCID: PMC3167088
View in: PubMed

104.Djulbegovic B, Angelotta C, Knox KE, Bennett CL. The sound and the fury: financial conflicts of interest in oncology. J Clin Oncol. .25(24):3567-9, 2007. PMID: 17704401
View in: PubMed

105.Angelotta C, McKoy JM, Fisher MJ, Buffie CG, Barfi K, Ramsey G, Frohlich L, Bennett CL. Legal, financial, and public health consequences of transfusion-transmitted hepatitis C virus in persons with haemophilia. Vox Sang. .93(2):159-65, 2007. PMID: 17683360
View in: PubMed

106.Courtney DM, Aldeen AZ, Gorman SM, Handler JA, Trifilio SM, Parada JP, Yarnold PR, Bennett CL. Cancer-associated neutropenic fever: clinical outcome and economic costs of emergency department care. Oncologist. .12(8):1019-26, 2007. PMID: 17766662
View in: PubMed

107.Fitzgibbon ML, Ferreira MR, Dolan NC, Davis TC, Rademaker AW, Wolf MS, Liu D, Gorby N, Schmitt BP, Bennett CL. Process evaluation in an intervention designed to improve rates of colorectal cancer screening in a VA medical center. Health Promot Pract. .8(3):273-81, 2007. PMID: 17606952
View in: PubMed

108.Tigue CC, McKoy JM, Evens AM, Trifilio SM, Tallman MS, Bennett CL. Granulocyte-colony stimulating factor administration to healthy individuals and persons with chronic neutropenia or cancer: an overview of safety considerations from the Research on Adverse Drug Events and Reports project. Bone Marrow Transplant. .40(3):185-92, 2007. PMID: 17563736
View in: PubMed

109.Bennett CL, Tigue CC, Angelotta C, McKoy JM, Edwards BJ. Adverse effects of drugs used to treat hematologic malignancies: surveillance efforts from the research on adverse drug events and reports project. Semin Thromb Hemost. .33(4):365-72, 2007. PMID: 17525894
View in: PubMed

110.McKoy JM, Fitzner KA, Edwards BJ, Alkhatib M, Tigue CC, Nonzee NJ, Bolden CR, Bennett CL. Cost considerations in the management of cancer in the older patient. Oncology (Williston Park). .21(7):851-7; discussion 858, 860, 862 passim, 2007. PMID: 17722744
View in: PubMed

111.Bennett CL, Nebeker JR, Yarnold PR, Tigue CC, Dorr DA, McKoy JM, Edwards BJ, Hurdle JF, West DP, Lau DT, Angelotta C, Weitzman SA, Belknap SM, Djulbegovic B, Tallman MS, Kuzel TM, Benson AB, Evens A, Trifilio SM, Courtney DM, Raisch DW. Evaluation of serious adverse drug reactions: a proactive pharmacovigilance program (RADAR) vs safety activities conducted by the Food and Drug Administration and pharmaceutical manufacturers. Arch Intern Med. .167(10):1041-9, 2007. PMID: 17533207
View in: PubMed

112.Beohar N, Davidson CJ, Kip KE, Goodreau L, Vlachos HA, Meyers SN, Benzuly KH, Flaherty JD, Ricciardi MJ, Bennett CL, Williams DO. Outcomes and complications associated with off-label and untested use of drug-eluting stents. JAMA. .297(18):1992-2000, 2007. PMID: 17488964
View in: PubMed

113.Evens AM, Cilley J, Ortiz T, Gounder M, Hou N, Rademaker A, Miyata S, Catsaros K, Augustyniak C, Bennett CL, Tallman MS, Variakojis D, Winter JN, Gordon LI. G-CSF is not necessary to maintain over 99% dose-intensity with ABVD in the treatment of Hodgkin lymphoma: low toxicity and excellent outcomes in a 10-year analysis. Br J Haematol. .137(6):545-52, 2007. PMID: 17459049
View in: PubMed

114.Loblaw DA, Virgo KS, Nam R, Somerfield MR, Ben-Josef E, Mendelson DS, Middleton R, Sharp SA, Smith TJ, Talcott J, Taplin M, Vogelzang NJ, Wade JL, Bennett CL, Scher HI. Initial hormonal management of androgen-sensitive metastatic, recurrent, or progressive prostate cancer: 2006 update of an American Society of Clinical Oncology practice guideline. J Clin Oncol. .25(12):1596-605, 2007. PMID: 17404365
View in: PubMed

115.Bennett CL, Calhoun EA. Evaluating the total costs of chemotherapy-induced febrile neutropenia: results from a pilot study with community oncology cancer patients. Oncologist. .12(4):478-83, 2007. PMID: 17470690
View in: PubMed

116.Hershman D, Neugut AI, Jacobson JS, Wang J, Tsai WY, McBride R, Bennett CL, Grann VR. Acute myeloid leukemia or myelodysplastic syndrome following use of granulocyte colony-stimulating factors during breast cancer adjuvant chemotherapy. J Natl Cancer Inst. .99(3):196-205, 2007. PMID: 17284714
View in: PubMed

117.Kyriacou DN, Yarnold PR, Stein AC, Schmitt BP, Soltysik RC, Nelson RR, Frerichs RR, Noskin GA, Belknap SM, Bennett CL. Discriminating inhalational anthrax from community-acquired pneumonia using chest radiograph findings and a clinical algorithm. Chest. .131(2):489-96, 2007. PMID: 17296652
View in: PubMed

118.Scheetz MH, McKoy JM, Parada JP, Djulbegovic B, Raisch DW, Yarnold PR, Zagory J, Trifilio S, Jakiche R, Palella F, Kahn A, Chandler K, Bennett CL. Systematic review of piperacillin-induced neutropenia. Drug Saf. .30(4):295-306, 2007. PMID: 17408306
View in: PubMed

119.Bennett CL, Tigue CC, Fitzner KA. The economics of brain metastases. Cancer Treat Res. .136:23-9, 2007. PMID: 18078263
View in: PubMed

120.Bennett CL, Angelotta C, Yarnold PR, Evens AM, Zonder JA, Raisch DW, Richardson P. Thalidomide- and lenalidomide-associated thromboembolism among patients with cancer. JAMA. .296(21):2558-60, 2006. PMID: 17148721
View in: PubMed

121.Wolf MS, Davis TC, Osborn CY, Skripkauskas S, Bennett CL, Makoul G. Literacy, self-efficacy, and HIV medication adherence. Patient Educ Couns. .65(2):253-60, 2006. PMID: 17118617
View in: PubMed

122.Bassuk AG, Chen YZ, Batish SD, Nagan N, Opal P, Chance PF, Bennett CL. In cis autosomal dominant mutation of Senataxin associated with tremor/ataxia syndrome. Neurogenetics. .8(1):45-9, 2006. PMID: 17096168
View in: PubMed

123.Bennett CL, Evens AM, Andritsos LA, Balasubramanian L, Mai M, Fisher MJ, Kuzel TM, Angelotta C, McKoy JM, Vose JM, Bierman PJ, Kuter DJ, Trifilio SM, Devine SM, Tallman MS. Haematological malignancies developing in previously healthy individuals who received haematopoietic growth factors: report from the Research on Adverse Drug Events and Reports (RADAR) project. Br J Haematol. .135(5):642-50, 2006. PMID: 17054431
View in: PubMed

124.Wagman LD, Baird MF, Bennett CL, Bockenstedt PL, Cataland SR, Fanikos J, Fogarty PF, Goldhaber SZ, Grover TS, Haire W, Hassoun H, Jahanzeb M, Leung LL, Linenberger ML, Millenson MM, Ortel TL, Salem R, Smith JL, Streiff MB. Venous thromboembolic disease. Clinical practice guidelines in oncology. J Natl Compr Canc Netw. .4(9):838-69, 2006. PMID: 17020664
View in: PubMed

125.McKoy JM, Angelotta C, Bennett CL, Tallman MS, Wadleigh M, Evens AM, Kuzel TM, Trifilio SM, Raisch DW, Kell J, DeAngelo DJ, Giles FJ. Gemtuzumab ozogamicin-associated sinusoidal obstructive syndrome (SOS): an overview from the research on adverse drug events and reports (RADAR) project. Leuk Res. .31(5):599-604, 2006. PMID: 16959316
View in: PubMed

126.Davis TC, Wolf MS, Bass PF, Middlebrooks M, Kennen E, Baker DW, Bennett CL, Durazo-Arvizu R, Bocchini A, Savory S, Parker RM. Low literacy impairs comprehension of prescription drug warning labels. J Gen Intern Med. .21(8):847-51, 2006. PMID: 16881945 PMCID: PMC1831578
View in: PubMed

127.Wolf MS, Knight SJ, Lyons EA, Durazo-Arvizu R, Pickard SA, Arseven A, Arozullah A, Colella K, Ray P, Bennett CL. Literacy, race, and PSA level among low-income men newly diagnosed with prostate cancer. Urology. .68(1):89-93, 2006. PMID: 16844451
View in: PubMed

128.Bohlius J, Wilson J, Seidenfeld J, Piper M, Schwarzer G, Sandercock J, Trelle S, Weingart O, Bayliss S, Djulbegovic B, Bennett CL, Langensiepen S, Hyde C, Engert A. Recombinant human erythropoietins and cancer patients: updated meta-analysis of 57 studies including 9353 patients. J Natl Cancer Inst. .98(10):708-14, 2006. PMID: 16705125
View in: PubMed

129.Smith TJ, Khatcheressian J, Lyman GH, Ozer H, Armitage JO, Balducci L, Bennett CL, Cantor SB, Crawford J, Cross SJ, Demetri G, Desch CE, Pizzo PA, Schiffer CA, Schwartzberg L, Somerfield MR, Somlo G, Wade JC, Wade JL, Winn RJ, Wozniak AJ, Wolff AC. 2006 update of recommendations for the use of white blood cell growth factors: an evidence-based clinical practice guideline. J Clin Oncol. .24(19):3187-205, 2006. PMID: 16682719
View in: PubMed

130.Adams JR, Angelotta C, Bennett CL. When the risk of febrile neutropenia is 20%, prophylactic colony-stimulating factor use is clinically effective, but is it cost-effective? J Clin Oncol. .24(19):2975-7, 2006. PMID: 16682722
View in: PubMed

131.Belknap SM, Kuzel TM, Yarnold PR, Slimack N, Lyons EA, Raisch DW, Bennett CL. Clinical features and correlates of gemcitabine-associated lung injury: findings from the RADAR project. Cancer. .106(9):2051-7, 2006. PMID: 16568459
View in: PubMed

132.Rintamaki LS, Davis TC, Skripkauskas S, Bennett CL, Wolf MS. Social stigma concerns and HIV medication adherence. AIDS Patient Care STDS. .20(5):359-68, 2006. PMID: 16706710
View in: PubMed

133.Bennett CL. Cosmology from start to finish. Nature. .440(7088):1126-31, 2006. PMID: 16641983
View in: PubMed

134.Wolf MS, Bennett CL. Local perspective of the impact of the HIPAA privacy rule on research. Cancer. .106(2):474-9, 2006. PMID: 16342254
View in: PubMed

135.Nebeker JR, Bennett CL. Reducing adverse drug events in the outpatient chemotherapy setting: attention must be paid. Cancer. .104(11):2289-91, 2005. PMID: 16245352
View in: PubMed

136.Wolf MS, Fitzner KA, Powell EF, McCaffrey KR, Pickard AS, McKoy JM, Lindenberg J, Schumock GT, Carson KR, Ferreira MR, Dolan NC, Bennett CL. Costs and cost effectiveness of a health care provider-directed intervention to promote colorectal cancer screening among Veterans. J Clin Oncol. .23(34):8877-83, 2005. PMID: 16314648
View in: PubMed

137.McKoy JM, Lyons EA, Obadina E, Carson K, Pickard AS, Schellhammer P, McLeod D, Boyd CE, McWilliams N, Sartor O, Schumock GT, McCaffery K, Bennett CL. Caveat medicus: consequences of federal investigations of marketing activities of pharmaceutical suppliers of prostate cancer drugs. J Clin Oncol. .23(34):8894-905, 2005. PMID: 16314650
View in: PubMed

138.Nebeker JR, Virmani R, Bennett CL, Hoffman JM, Samore MH, Alvarez J, Davidson CJ, McKoy JM, Raisch DW, Whisenant BK, Yarnold PR, Belknap SM, West DP, Gage JE, Morse RE, Gligoric G, Davidson L, Feldman MD. Hypersensitivity cases associated with drug-eluting coronary stents: a review of available cases from the Research on Adverse Drug Events and Reports (RADAR) project. J Am Coll Cardiol. .47(1):175-81, 2005. PMID: 16386683
View in: PubMed

139.Kwaan HC, Bennett CL. Thrombotic thrombocytopenic purpura-2005. Semin Thromb Hemost. .31(6):611-4, 2005. PMID: 16388411
View in: PubMed

140.Wolf MS, Davis TC, Arozullah A, Penn R, Arnold C, Sugar M, Bennett CL. Relation between literacy and HIV treatment knowledge among patients on HAART regimens. AIDS Care. .17(7):863-73, 2005. PMID: 16120503
View in: PubMed

141.Djulbegovic B, Frohlich A, Bennett CL. Acting on imperfect evidence: How much regret are we ready to accept? J Clin Oncol. .23(28):6822-5, 2005. PMID: 16145058
View in: PubMed

142.Wolf MS, Bennett CL, Davis TC, Marin E, Arnold C. A qualitative study of literacy and patient response to HIV medication adherence questionnaires. J Health Commun. .10(6):509-17, 2005. PMID: 16203630
View in: PubMed

143.Bennett CL, Cournoyer D, Carson KR, Rossert J, Luminari S, Evens AM, Locatelli F, Belknap SM, McKoy JM, Lyons EA, Kim B, Sharma R, Costello S, Toffelmire EB, Wells GA, Messner HA, Yarnold PR, Trifilio SM, Raisch DW, Kuzel TM, Nissenson A, Lim LC, Tallman MS, Casadevall N. Long-term outcome of individuals with pure red cell aplasia and antierythropoietin antibodies in patients treated with recombinant epoetin: a follow-up report from the Research on Adverse Drug Events and Reports (RADAR) Project. Blood. .106(10):3343-7, 2005. PMID: 16099877 PMCID: PMC1895064
View in: PubMed

144.Pickard AS, Hung SY, McKoy JM, Witt WP, Arseven A, Sharifi R, Wu Z, Knight SJ, McWilliams N, Schumock GT, Bennett CL. Opportunities for disease state management in prostate cancer. Dis Manag. .8(4):235-44, 2005. PMID: 16117718
View in: PubMed

145.Dolan NC, Ferreira MR, Fitzgibbon ML, Davis TC, Rademaker AW, Liu D, Lee J, Wolf M, Schmitt BP, Bennett CL. Colorectal cancer screening among African-American and white male veterans. Am J Prev Med. .28(5):479-82, 2005. PMID: 15894152
View in: PubMed

146.Kramer KM, Bennett CL, Pickard AS, Lyons EA, Wolf MS, McKoy JM, Knight SJ. Patient preferences in prostate cancer: a clinician's guide to understanding health utilities. Clin Prostate Cancer. .4(1):15-23, 2005. PMID: 15992457
View in: PubMed

147.Nebeker JR, Hoffman JM, Weir CR, Bennett CL, Hurdle JF. High rates of adverse drug events in a highly computerized hospital. Arch Intern Med. .165(10):1111-6, 2005. PMID: 15911723
View in: PubMed

148.Bennett CL, Nebeker JR, Lyons EA, Samore MH, Feldman MD, McKoy JM, Carson KR, Belknap SM, Trifilio SM, Schumock GT, Yarnold PR, Davidson CJ, Evens AM, Kuzel TM, Parada JP, Cournoyer D, West DP, Sartor O, Tallman MS, Raisch DW. The Research on Adverse Drug Events and Reports (RADAR) project. JAMA. .293(17):2131-40, 2005. PMID: 15870417
View in: PubMed

149.Passman RS, Gingold DS, Amar D, Lloyd-Jones D, Bennett CL, Zhang H, Rusch VW. Prediction rule for atrial fibrillation after major noncardiac thoracic surgery. Ann Thorac Surg. .79(5):1698-703, 2005. PMID: 15854958
View in: PubMed

150.Zakarija A, Bennett CL. Low-molecular-weight heparins: do we have the GUSTO to identify differences between alternative formulations? Arch Intern Med. .165(7):722-3, 2005. PMID: 15824289
View in: PubMed

151.Wolf MS, Rademaker A, Bennett CL, Ferreira MR, Dolan NC, Davis TC, Medio F, Liu D, Lee J, Fitzgibbon M. Development of a brief survey on colon cancer screening knowledge and attitudes among veterans. Prev Chronic Dis. .2(2):A11, 2005. PMID: 15888222 PMCID: PMC1327705
View in: PubMed

152.Ferreira MR, Dolan NC, Fitzgibbon ML, Davis TC, Gorby N, Ladewski L, Liu D, Rademaker AW, Medio F, Schmitt BP, Bennett CL. Health care provider-directed intervention to increase colorectal cancer screening among veterans: results of a randomized controlled trial. J Clin Oncol. .23(7):1548-54, 2005. PMID: 15735130
View in: PubMed

153.Bennett CL. Astrophysical observations: lensing and eclipsing Einstein's theories. Science. .307(5711):879-84, 2005. PMID: 15705841
View in: PubMed

154.Rozovsky-Weinberger J, Parada JP, Phan L, Droller DG, Deloria-Knoll M, Chmiel JS, Bennett CL. Delays in suspicion and isolation among hospitalized persons with pulmonary tuberculosis at public and private US hospitals during 1996 to 1999. Chest. .127(1):205-12, 2005. PMID: 15653985
View in: PubMed

155.Bennett CL. The blue cross blue shield assessment technology review: summary of findings. Best Pract Res Clin Haematol. .18(3):423-31, 2005. PMID: 15792916
View in: PubMed

156.Bohlius JF, Langensiepen S, Engert A, Schwarzer G, Bennett CL. Effectiveness of erythropoietin in the treatment of patients with malignancies: methods and preliminary results of a Cochrane review. Best Pract Res Clin Haematol. .18(3):449-54, 2005. PMID: 15792919
View in: PubMed

157.Carson KR, Evens AM, Bennett CL, Luminari S. Clinical characteristics of erythropoietin-associated pure red cell aplasia. Best Pract Res Clin Haematol. .18(3):467-72, 2005. PMID: 15792921
View in: PubMed

158.Evens AM, Bennett CL, Luminari S. Epoetin-induced pure red-cell aplasia (PRCA): preliminary results from the research on adverse drug events and reports (RADAR) group. Best Pract Res Clin Haematol. .18(3):481-9, 2005. PMID: 15792923
View in: PubMed

159.Calhoun EA, Schumock GT, McKoy JM, Pickard S, Fitzner KA, Heckinger EA, Powell EF, McCaffrey KR, Bennett CL. Granulocyte colony--stimulating factor for chemotherapy-induced neutropenia in patients with small cell lung cancer : the 40% rule revisited. Pharmacoeconomics. .23(8):767-75, 2005. PMID: 16097839
View in: PubMed

160.Macpherson GR, Singh AS, Bennett CL, Venzon DJ, Liewehr DJ, Franks ME, Dahut WL, Kantoff PW, Price DK, Figg WD. Genotyping and functional analysis of the D104N variant of human endostatin. Cancer Biol Ther. .3(12):1298-303, 2004. PMID: 15662127
View in: PubMed

161.Bennett CL, Calhoun EA. Pharmacoeconomics of liposomal anthracycline therapy. Semin Oncol. .31(6 Suppl 13):191-5, 2004. PMID: 15717744
View in: PubMed

162.Wolf MS, Davis TC, Cross JT, Marin E, Green K, Bennett CL. Health literacy and patient knowledge in a Southern US HIV clinic. Int J STD AIDS. .15(11):747-52, 2004. PMID: 15537462
View in: PubMed

163.Bennett CL, Luminari S, Nissenson AR, Tallman MS, Klinge SA, McWilliams N, McKoy JM, Kim B, Lyons EA, Trifilio SM, Raisch DW, Evens AM, Kuzel TM, Schumock GT, Belknap SM, Locatelli F, Rossert J, Casadevall N. Pure red-cell aplasia and epoetin therapy. N Engl J Med. .351(14):1403-8, 2004. PMID: 15459301
View in: PubMed

164.Chang S, Long SR, Kutikova L, Bowman L, Finley D, Crown WH, Bennett CL. Estimating the cost of cancer: results on the basis of claims data analyses for cancer patients diagnosed with seven types of cancer during 1999 to 2000. J Clin Oncol. .22(17):3524-30, 2004. PMID: 15337801
View in: PubMed

165.Dolan NC, Ferreira MR, Davis TC, Fitzgibbon ML, Rademaker A, Liu D, Schmitt BP, Gorby N, Wolf M, Bennett CL. Colorectal cancer screening knowledge, attitudes, and beliefs among veterans: does literacy make a difference? J Clin Oncol. .22(13):2617-22, 2004. PMID: 15226329
View in: PubMed

166.Golub RM, Bennett CL, Stinson T, Venta L, Morrow M. Cost minimization study of image-guided core biopsy versus surgical excisional biopsy for women with abnormal mammograms. J Clin Oncol. .22(12):2430-7, 2004. PMID: 15197205
View in: PubMed

167.Loblaw DA, Mendelson DS, Talcott JA, Virgo KS, Somerfield MR, Ben-Josef E, Middleton R, Porterfield H, Sharp SA, Smith TJ, Taplin ME, Vogelzang NJ, Wade JL, Bennett CL, Scher HI. American Society of Clinical Oncology recommendations for the initial hormonal management of androgen-sensitive metastatic, recurrent, or progressive prostate cancer. J Clin Oncol. .22(14):2927-41, 2004. PMID: 15184404
View in: PubMed

168.Elstein AS, Chapman GB, Chmiel JS, Knight SJ, Chan C, Nadler RB, Kuzel TM, Siston AK, Bennett CL. Agreement between prostate cancer patients and their clinicians about utilities and attribute importance. Health Expect. .7(2):115-25, 2004. PMID: 15117386
View in: PubMed

169.Knight SJ, Siston AK, Chmiel JS, Slimack N, Elstein AS, Chapman GB, Nadler RB, Bennett CL. Ethnic variation in localized prostate cancer: a pilot study of preferences, optimism, and quality of life among black and white veterans. Clin Prostate Cancer. .3(1):31-7, 2004. PMID: 15279688
View in: PubMed

170.Arozullah AM, Calhoun EA, Wolf M, Finley DK, Fitzner KA, Heckinger EA, Gorby NS, Schumock GT, Bennett CL. The financial burden of cancer: estimates from a study of insured women with breast cancer. J Support Oncol. .2(3):271-8, 2004. PMID: 15328826
View in: PubMed

171.Calhoun EA, Fishman DA, Lurain JR, Welshman EE, Bennett CL. A comparison of ovarian cancer treatments: analysis of utility assessments of ovarian cancer patients, at-risk population, general population, and physicians. Gynecol Oncol. .93(1):164-9, 2004. PMID: 15047231
View in: PubMed

172.Uphold CR, Deloria-Knoll M, Palella FJ, Parada JP, Chmiel JS, Phan L, Bennett CL. US hospital care for patients with HIV infection and pneumonia: the role of public, private, and Veterans Affairs hospitals in the early highly active antiretroviral therapy era. Chest. .125(2):548-56, 2004. PMID: 14769737
View in: PubMed

173.Sureka A, Parada JP, Deloria-Knoll M, Chmiel JS, Phan L, Lyons TM, Ali S, Yarnold PR, Weinstein RA, Dehovitz JA, Jacobson JM, Goetz MB, Campo RE, Berland D, Bennett CL, Uphold CR. HIV-related pneumonia care in older patients hospitalized in the early HAART era. AIDS Patient Care STDS. .18(2):99-107, 2004. PMID: 15006184
View in: PubMed

174.Zakarija A, Bandarenko N, Pandey DK, Auerbach A, Raisch DW, Kim B, Kwaan HC, McKoy JM, Schmitt BP, Davidson CJ, Yarnold PR, Gorelick PB, Bennett CL. Clopidogrel-associated TTP: an update of pharmacovigilance efforts conducted by independent researchers, pharmaceutical suppliers, and the Food and Drug Administration. Stroke. .35(2):533-7, 2004. PMID: 14707231
View in: PubMed

175.Adams JR, Elting LS, Lyman GH, George JN, Lembersky BC, Armitage JO, Demetri GD, Bennett CL. Use of erythropoietin in cancer patients: assessment of oncologists' practice patterns in the United States and other countries. Am J Med. .116(1):28-34, 2004. PMID: 14706663
View in: PubMed

176.Kim SP, Feinglass J, Bennett CL, Lyons T, Simon C, Weinberg MN, Talamonti MS. Merging claims databases with a tumor registry to evaluate variations in cancer mortality: results from a pilot study of 698 colorectal cancer patients treated at one hospital in the 1990s. Cancer Invest. .22(2):225-33, 2004. PMID: 15199605
View in: PubMed

177.Parada JP, Deloria-Knoll M, Chmiel JS, Arozullah AM, Phan L, Ali SN, Goetz MB, Weinstein RA, Campo R, Jacobson J, Dehovitz J, Berland D, Bennett CL. Relationship between health insurance and medical care for patients hospitalized with human immunodeficiency virus-related Pneumocystis carinii pneumonia, 1995-1997: Medicaid, bronchoscopy, and survival. Clin Infect Dis. .37(11):1549-55, 2003. PMID: 14614679
View in: PubMed

178.Ladewski LA, Belknap SM, Nebeker JR, Sartor O, Lyons EA, Kuzel TC, Tallman MS, Raisch DW, Auerbach AR, Schumock GT, Kwaan HC, Bennett CL. Dissemination of information on potentially fatal adverse drug reactions for cancer drugs from 2000 to 2002: first results from the research on adverse drug events and reports project. J Clin Oncol. .21(20):3859-66, 2003. PMID: 14551305
View in: PubMed

179.Bennett CL. Cost analyses of granulocyte colony stimulating factor: a focus on older patients with cancer. Crit Rev Oncol Hematol. .48(Suppl):S71-4, 2003. PMID: 14563524
View in: PubMed

180.Talamonti MS, Kim SP, Yao KA, Wayne JD, Feinglass J, Bennett CL, Rao S. Surgical outcomes of patients with gastric carcinoma: the importance of primary tumor location and microvessel invasion. Surgery. .134(4):720-7; discussion 727-9, 2003. PMID: 14605635
View in: PubMed

181.Arozullah AM, Parada J, Bennett CL, Deloria-Knoll M, Chmiel JS, Phan L, Yarnold PR. A rapid staging system for predicting mortality from HIV-associated community-acquired pneumonia. Chest. .123(4):1151-60, 2003. PMID: 12684306
View in: PubMed

182.Bennett CL, Somerfield MR, Pfister DG, Tomori C, Yakren S, Bach PB. Perspectives on the value of American Society of Clinical Oncology clinical guidelines as reported by oncologists and health maintenance organizations. J Clin Oncol. .21(5):937-41, 2003. PMID: 12610197
View in: PubMed

183.MacDonald LA, Meyers S, Bennett CL, Fintel D, Grosshans N, Syegco R, Davidson CJ. Post-cardiac catheterization access site complications and low-molecular -weight heparin following cardiac catheterization. J Invasive Cardiol. .15(2):60-2, 2003. PMID: 12556615
View in: PubMed

184.Siston AK, Knight SJ, Slimack NP, Chmiel JS, Nadler RB, Lyons TM, Kuzel TM, Moran EM, Sharifi R, Bennett CL. Quality of life after a diagnosis of prostate cancer among men of lower socioeconomic status: results from the Veterans Affairs Cancer of the Prostate Outcomes Study. Urology. .61(1):172-8, 2003. PMID: 12559291
View in: PubMed

185.Calhoun EA, Bennett CL. Evaluating the total costs of cancer. The Northwestern University Costs of Cancer Program. Oncology (Williston Park). .17(1):109-14; discussion 119-21, 2003. PMID: 12599935
View in: PubMed

186.Bennett CL, Schumock GT. Cost analyses of adjunct colony stimulating factors for older patients with acute myeloid leukaemia : can they improve clinical decision making? Drugs Aging. .20(7):479-83, 2003. PMID: 12749746
View in: PubMed

187.Bennett CL, Schumock GT, Desai AA, Kwaan HC, Raisch DW, Newlin R, Stadler W. Thalidomide-associated deep vein thrombosis and pulmonary embolism. Am J Med. .113(7):603-6, 2002. PMID: 12459408
View in: PubMed

188.Rizzo JD, Lichtin AE, Woolf SH, Seidenfeld J, Bennett CL, Cella D, Djulbegovic B, Goode MJ, Jakubowski AA, Lee SJ, Miller CB, Rarick MU, Regan DH, Browman GP, Gordon MS. Use of epoetin in patients with cancer: evidence-based clinical practice guidelines of the American Society of Clinical Oncology and the American Society of Hematology. Blood. .100(7):2303-20, 2002. PMID: 12239138
View in: PubMed

189.Rizzo JD, Lichtin AE, Woolf SH, Seidenfeld J, Bennett CL, Cella D, Djulbegovic B, Goode MJ, Jakubowski AA, Lee SJ, Miller CB, Rarick MU, Regan DH, Browman GP, Gordon MS. Use of epoetin in patients with cancer: evidence-based clinical practice guidelines of the American Society of Clinical Oncology and the American Society of Hematology. J Clin Oncol. .20(19):4083-107, 2002. PMID: 12351606
View in: PubMed

190.Bennett CL, Raisch DW, Sartor O. Pneumonitis associated with nonsteroidal antiandrogens: presumptive evidence of a class effect. Ann Intern Med. .137(7):625, 2002. PMID: 12353966
View in: PubMed

191.Evens AM, Kwaan HC, Kaufman DB, Bennett CL. TTP/HUS occurring in a simultaneous pancreas/kidney transplant recipient after clopidogrel treatment: evidence of a nonimmunological etiology. Transplantation. .74(6):885-7, 2002. PMID: 12364873
View in: PubMed

192.Clark O, Adams JR, Bennett CL, Djulbegovic B. Erythropoietin, uncertainty principle and cancer related anaemia. BMC Cancer. .2:23, 2002. PMID: 12270068 PMCID: PMC130027
View in: PubMed

193.Adams JR, Lyman GH, Djubegovic B, Feinglass J, Bennett CL. G-CSF as prophylaxis of febrile neutropenia in SCLC. Expert Opin Pharmacother. .3(9):1273-81, 2002. PMID: 12186620
View in: PubMed

194.Bennett CL, Price DK, Kim S, Liu D, Jovanovic BD, Nathan D, Johnson ME, Montgomery JS, Cude K, Brockbank JC, Sartor O, Figg WD. Racial variation in CAG repeat lengths within the androgen receptor gene among prostate cancer patients of lower socioeconomic status. J Clin Oncol. .20(17):3599-604, 2002. PMID: 12202660
View in: PubMed

195.Knight SJ, Nathan DP, Siston AK, Kattan MW, Elstein AS, Collela KM, Wolf MS, Slimack NS, Bennett CL, Golub RM. Pilot study of a utilities-based treatment decision intervention for prostate cancer patients. Clin Prostate Cancer. .1(2):105-14, 2002. PMID: 15046701
View in: PubMed

196.Johnson S, Chan J, Bennett CL. Hepatotoxicity after prophylaxis with a nevirapine-containing antiretroviral regimen. Ann Intern Med. .137(2):146-7, 2002. PMID: 12118982
View in: PubMed

197.Samson DJ, Seidenfeld J, Schmitt B, Hasselblad V, Albertsen PC, Bennett CL, Wilt TJ, Aronson N. Systematic review and meta-analysis of monotherapy compared with combined androgen blockade for patients with advanced prostate carcinoma. Cancer. .95(2):361-76, 2002. PMID: 12124837
View in: PubMed

198.Golub R, Adams J, Dave S, Bennett CL. Cost-effectiveness considerations in the treatment of essential thrombocythemia. Semin Oncol. .29(3 Suppl 10):28-32, 2002. PMID: 12096355
View in: PubMed

199.Lindau ST, Tomori C, Lyons T, Langseth L, Bennett CL, Garcia P. The association of health literacy with cervical cancer prevention knowledge and health behaviors in a multiethnic cohort of women. Am J Obstet Gynecol. .186(5):938-43, 2002. PMID: 12015518
View in: PubMed

200.Adams JR, Nathan DP, Bennett CL. Pharmacoeconomics of therapy for ITP: steroids, i.v.Ig, anti-D, and splenectomy. Blood Rev. .16(1):65-7, 2002. PMID: 11913999
View in: PubMed

201.Weinberg PD, Hounshell J, Sherman LA, Godwin J, Ali S, Tomori C, Bennett CL. Legal, financial, and public health consequences of HIV contamination of blood and blood products in the 1980s and 1990s. Ann Intern Med. .136(4):312-9, 2002. PMID: 11848729
View in: PubMed

202.Kim B, Lyons TM, Parada JP, Uphold CR, Yarnold PR, Hounshell JB, Sipler AM, Goetz MB, DeHovitz JA, Weinstein RA, Campo RE, Bennett CL. HIV-related Pneumocystis carinii pneumonia in older patients hospitalized in the early HAART era. J Gen Intern Med. .16(9):583-9, 2001. PMID: 11556938 PMCID: PMC1495267
View in: PubMed

203.Bennett CL, Crane JM. Quality improvement efforts in oncology: are we ready to begin? Cancer Invest. .19(1):86-95, 2001. PMID: 11291561
View in: PubMed

204.Calhoun EA, Chang CH, Welshman EE, Fishman DA, Lurain JR, Bennett CL. Evaluating the total costs of chemotherapy-induced toxicity: results from a pilot study with ovarian cancer patients. Oncologist. .6(5):441-5, 2001. PMID: 11675522
View in: PubMed